新闻中心/瑞联卓见

In the latest episode of UBP’s Expert series, Norman Villamin, CIO Wealth Management and Pierre Corby, Equity Analyst Healthcare, invited Dr Samarth Kulkarni, CEO of CRISPR Therapeutics, to discuss the challenges and investment opportunities offered by medical innovation, specifically in the field of gene editing.

怀抱转变

Institutional Money (8.11.2021) - Coming into the final quarter of the year, our view had been that the economic recovery would allow central banks to start guiding towards less accommodative policies, and that this would provide room for rates to rise. 

The 2015 Paris Agreement called for a 5-year cycle of updates on nationally determined contributions (NDC). This latest update would have occurred in 2020 but was postponed due to the COVID-19 pandemic.

Investment Week (10.11.2021) - As sustainable investing has gathered momentum over the last decade, much of the focus of the underlying investments has been on climate stability and, more specifically, carbon intensity. 

Having been dormant for nearly 50 years, the term ‘stagflation’ has once again re-entered investors’ lexicon and with it a concern of a lost decade like the one faced by investors in the US in the 1970s.

The Chinese economy is facing headwinds leading into 2022, including: 1) Ongoing regulatory crackdown; 2) Exposure to COVID outbreaks; 3) A slump in the housing sector; and 4) Power shortages over the winter months.

With the 26th United Nations Climate Change Conference currently underway in Glasgow, Union Bancaire Privée's Impact Investing team has compiled a list of important areas to focus on. The outcome of the conference will be crucial in determining how humanity can mitigate and adapt to climate change.

Financial Investigator (01.10.2021) - Private debt can boost the supply of social and affordable housing, for the benefit of investors and low-income residents alike. We see potential for a long-running investment theme. 

Wealth Magazine (22.10.2021) - Frontier markets offer an attractive investment opportunity, as a separate investment from global EMD, for several reasons. The most obvious is that returns have outpaced broader sovereign EMD through all relevant periods. 

In the United States, the Covid-19 Delta variant is continuing to wreak havoc, causing concern that the recovery could be derailed. However, there are reasons to be optimistic about the US equity market, with companies having posted exceptional earnings over the second quarter. Looking ahead, a focus on long-term, sustainable, quality, growth companies is the right approach to capture returns.

London, 12 October 2021 - With the UN Biodiversity Conference (COP15) under way this week in Kunming, China, Union Bancaire Privée’s (UBP) Impact Investing team has called on delegates to match their ambitions on the protection of global biodiversity by issuing four “wishes” for commitments at the Conference.